Search Results - "Frenay, C"

Infectious myelitis by Lebrun Frenay, C.

“…Infectious pathogens can directly affect the spinal cord or trigger autoimmune reactions, which may result in permanent damage to cord structures. The most…”
Get full text

Pregnancy with multiple sclerosis by Vukusic, S., Michel, L., Leguy, S., Lebrun-Frenay, C.

“…Multiple sclerosis (MS) is usually diagnosed between twenty and forty years of age, when people often plan to have children. A lot has been said about the…”
Get full text

French validation of the sexual complaints screener (SCS) for patients with multiple sclerosis by Bresch, S., Joly, H., Colamarino, R., Bentellis, I., Tur, S., Fakir, S., Burte, C., Lebrun-Frenay, C.

“…Sexual dysfunctions are frequent in the general population and even more frequent in individuals with chronic neurological disorders like multiple sclerosis…”
Get full text

Covid-19, the pandemic war: Implication for neurologists by de Seze, J., Lebrun-Frenay, C.

Get full text

Early treatment with rituximab in Susac syndrome by Mazloum, M.P., Cohen, M., Bresch, S., Mondot, L., Levraut, M., Lebrun-Frenay, C.

“…•Susac syndrome is a rare micro vasculitis affecting cerebral, retinal, and cochlear vessels, that affects mostly young patients and can lead to severe…”
Get full text

Alexithymia in multiple sclerosis: Clinical and radiological correlations by Capet, N., Joly, H., Suply, C., Mondot, L., Cohen, M., Lebrun-Frenay, C.

“…Alexithymia, meaning no words for emotions is a common problem that could affect up to 53% of patients in multiple sclerosis (MS). To determine the frequency…”
Get full text

Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI by Landes-Chateau, C., Levraut, M., Cohen, M., Sicard, M., Papeix, C., Cotton, F., Balcerac, A., Themelin, A., Mondot, L., Lebrun-Frenay, C.

“…INTRODUCTIONWhite matter lesions (WML) on magnetic resonance imaging (MRI) are common in clinical practice. When analyzing WML, radiologists sometimes propose…”
Get full text

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study by Siri, A., Carra-Dalliere, Clarisse, Ayrignac, X., Pelletier, J., Audoin, B., Pittion-Vouyovitch, S., Debouverie, M., Lionnet, C., Viala, F., Sablot, D., Brassat, D., Ouallet, J.-C., Ruet, A., Brochet, B., Taillandier, L., Bauchet, L., Derache, N., Defer, G., Cabre, P., de Seze, J., Lebrun Frenay, C., Cohen, M., Labauge, P.

“…Isolated tumefactive demyelinating lesion (TDL) is a rare disease and a challenging entity especially for the differential diagnosis, biopsy indications, and…”
Get full text

Neuromyelitis optica in France: A multicenter study of 125 patients by COLLONGUES, N, MARIGNIER, R, FONTAINE, B, BRASSAT, D, CLANET, M, MILH, M, PELLETIER, J, AUDOIN, B, RUET, A, LEBRUN-FRENAY, C, THOUVENOT, E, CAMU, W, ZEPHIR, H, DEBOUVERIE, M, CREANGE, A, MOREAU, T, LABAUGE, P, CASTELNOVO, G, EDAN, G, LE PAGE, E, DEFER, G, BARROSO, B, HEINZLEF, O, PAPEIX, C, GOUT, O, RODRIGUEZ, D, WIERTLEWSKI, S, LAPLAUD, D, BORGEL, F, TOURNIAIRE, P, GRIMAUD, J, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, BLANC, F, DE SEZE, J, RITLENG, C, TCHIKVILADZE, M, OUTTERYCK, O, VUKUSIC, S, FLEURY, M

“…There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical,…”
Get full text

The French National Mesothelioma Surveillance Program by Goldberg, M, Imbernon, E, Rolland, P, Soit Ilg, A Gilg, Savès, M, de Quillacq, A, Frenay, C, Chamming’s, S, Arveux, P, Boutin, C, Launoy, G, Pairon, J C, Astoul, P, Galateau-Sallé, F, Brochard, P

“…Objectives: The French National Mesothelioma Surveillance Program (NMSP) was established in 1998 by the National Institute for Health Surveillance (InVS). Its…”
Get full text

Virologically suppressed patients with asymptomatic and symptomatic HIV‐associated neurocognitive disorders do not display the same pattern of immune activation by Vassallo, M, Durant, J, Lebrun‐Frenay, C, Fabre, R, Ticchioni, M, Andersen, S, DeSalvador, F, Harvey‐Langton, A, Dunais, B, Cohen‐Codar, I, Montagne, N, Cua, E, Fredouille‐Heripret, L, Laffon, M, Cottalorda, J, Dellamonica, P, Pradier, C

“…Objectives Inversion of the CD4:CD8 ratio is a marker of immune activation and age‐associated disease. We measured the CD4:CD8 ratio as a marker of cognitive…”
Get full text

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication by Vassallo, Matteo, Fabre, R., Durant, J., Lebrun-Frenay, C., Joly, H., Ticchioni, M., DeSalvador, F., Harvey-Langton, A., Dunais, B., Laffon, M., Cottalorda, J., Dellamonica, P., Pradier, C.

“…Persistent immune activation is one of the suspected causes of HIV-associated neurocognitive disorders (HAND) in cART era. The CD4/CD8 ratio has been recently…”
Get full text

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort by Outteryck, O., Ongagna, J.C., Brochet, B., Rumbach, L., Lebrun-Frenay, C., Debouverie, M., Zéphir, H., Ouallet, J.C., Berger, E., Cohen, M., Pittion, S., Laplaud, D., Wiertlewski, S., Cabre, P., Pelletier, J., Rico, A., Defer, G., Derache, N., Camu, W., Thouvenot, E., Moreau, T., Fromont, A., Tourbah, A., Labauge, P., Castelnovo, G., Clavelou, P., Casez, O., Hautecoeur, P., Papeix, C., Lubetzki, C., Fontaine, B., Couturier, N., Bohossian, N., Clanet, M., Vermersch, P., de Sèze, J., Brassat, D.

“…Background and purpose BIONAT is a French multicentric phase IV study of natalizumab (NTZ)‐treated relapsing−remitting multiple sclerosis (MS) patients. The…”
Get full text

Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions by Lebrun-Frenay, C

Get full text

Multiple sclerosis treatments and the anti-JCV antibody index by de Seze, J., Lebrun-Frenay, C.

Get full text

Video-oculography in multiple sclerosis: Links between oculomotor disorders and brain magnetic resonance imaging (MRI) by Polet, K., Hesse, S., Cohen, M., Morisot, A., Joly, H., Kullmann, B., Mondot, L., Pesce, A., Lebrun-Frenay, C.

“…•Video-oculography is a useful technic to confirm early demyelinating process.•Eye movement abnormalities are common in all MS phenotypes even at the early…”
Get full text

Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis by Joly, H., Capet, N., Mondot, L., Cohen, M., Suply, C., Bresch, S., Lebrun-Frenay, C.

“…•A high dysfunctional impulsivity is present in some cases of Multiple Sclerosis.•Progressive forms do not show higher impulsivity probably due to a lack of…”
Get full text

Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS? by Van Obberghen, E.K., Cohen, M., Rocher, F., Lebrun-Frenay, C.

“…Natalizumab (NTZ) is an effective treatment for patients with highly active relapsing remitting multiple sclerosis (MS). However, when the therapy must be…”
Get full text

Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab by Romero, G., Ticchioni, M., Cohen, M., Rosenthal-Allieri, M.A., Mondot, L., Lebrun Frenay, C.

“…Neuromyelitis optica (NMO) is a central nervous system inflammatory autoimmune disease characterized by medullary and/or optical nerve damage. It is rare but…”
Get full text

Prior suggestive symptoms in one-third of patients consulting for a “first” demyelinating event by Gout, O, Lebrun-Frenay, C, Labauge, P, Le Page, G E, Clavelou, P, Allouche, S

“…ObjectiveTo evaluate the prevalence of prior inflammatory events in patients consulting for a first inflammatory neurological event and improve early diagnosis…”
Get full text